Cargando…

3D printed multi-drug-loaded suppositories for acute severe ulcerative colitis

Acute severe ulcerative colitis (ASUC) is a growing health burden that often requires treatment with multiple therapeutic agents. As inflammation is localised in the rectum and colon, local drug delivery using suppositories could improve therapeutic outcomes. Three-dimensional (3D) printing is a nov...

Descripción completa

Detalles Bibliográficos
Autores principales:	Awad, Atheer, Hollis, Eleanor, Goyanes, Alvaro, Orlu, Mine, Gaisford, Simon, Basit, Abdul W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Special Issue on Interreg project “Site-Specific Drug Delivery”
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982042/ https://www.ncbi.nlm.nih.gov/pubmed/36876053 http://dx.doi.org/10.1016/j.ijpx.2023.100165

Ejemplares similares

3D printed infliximab suppositories for rectal biologic delivery
por: Awad, Atheer, et al.
Publicado: (2023)

Predicting pharmaceutical inkjet printing outcomes using machine learning
por: Carou-Senra, Paola, et al.
Publicado: (2023)

The Dynamic Intestinal Absorption Model (Diamod®), an in vitro tool to study the interconnected kinetics of gastrointestinal solubility, supersaturation, precipitation, and intestinal permeation processes of oral drugs
por: Moens, Frédéric, et al.
Publicado: (2023)

At-line porosity sensing for non-destructive disintegration testing in immediate release tablets
por: Bawuah, Prince, et al.
Publicado: (2023)

3D printed tacrolimus suppositories for the treatment of ulcerative colitis
por: Seoane-Viaño, Iria, et al.
Publicado: (2021)

3D Printed Tablets (Printlets) with Braille and Moon Patterns for Visually Impaired Patients
por: Awad, Atheer, et al.
Publicado: (2020)

Printing Drugs onto Nails for Effective Treatment of Onychomycosis
por: Pollard, Thomas D., et al.
Publicado: (2022)

3D Printed Pellets (Miniprintlets): A Novel, Multi-Drug, Controlled Release Platform Technology
por: Awad, Atheer, et al.
Publicado: (2019)

3D Printing of a Multi-Layered Polypill Containing Six Drugs Using a Novel Stereolithographic Method
por: Robles-Martinez, Pamela, et al.
Publicado: (2019)

ROS Modulating Inorganic Nanoparticles: A Novel Cancer Therapeutic Tool
por: Newton Amaldoss, Maria John, et al.
Publicado: (2022)

Recent Patents on Nasal Vaccines Containing Nanoadjuvants
por: Candela, Francesco, et al.
Publicado: (2022)

Optimizing and Evaluating the Transdermal Permeation of Hydrocortisone Transfersomes Formulation Based on Digital Analysis of the In Vitro Drug Release and Ex Vivo Studies
por: Abdelwahd, Asmae, et al.
Publicado: (2022)

3D Printing of Tunable Zero-Order Release Printlets
por: Fina, Fabrizio, et al.
Publicado: (2020)

Inkjet drug printing onto contact lenses: Deposition optimisation and non-invasive dose verification
por: Pollard, Thomas D., et al.
Publicado: (2022)

Releasing fast and slow: Non-destructive prediction of density and drug release from SLS 3D printed tablets using NIR spectroscopy
por: Trenfield, Sarah J., et al.
Publicado: (2022)

Innovations in Chewable Formulations: The Novelty and Applications of 3D Printing in Drug Product Design
por: Rodríguez-Pombo, Lucía, et al.
Publicado: (2022)

Machine Learning and Machine Vision Accelerate 3D Printed Orodispersible Film Development
por: O’Reilly, Colm S., et al.
Publicado: (2021)

Virtually Possible: Enhancing Quality Control of 3D-Printed Medicines with Machine Vision Trained on Photorealistic Images
por: Sun, Siyuan, et al.
Publicado: (2023)

Golimumab for the treatment of ulcerative colitis
por: Flamant, Mathurin, et al.
Publicado: (2017)

Summary of the Replies to the Questionnaire on General Site Information (CERN/CC/635/Annex I)
Publicado: (1967)

Summary of the Replies to the Questionnaire on General Site Information (CERN/CC/635/Annex I)
Publicado: (1967)

Comments on the Summary of the Replies to the Questionnaire on General Site Information and on the Report of the Site Evaluation Panel on the Site Offers by the Member States for the 300 GeV Accelerator Laboratory (CERN/760, CERN/761) Note by the Swedish Atomic Research Council
Publicado: (1968)

Policy Guidance for Site Selection
Publicado: (1966)

Journey from clinical practice to clinical research
por: Fulwani, Mahesh, et al.
Publicado: (2013)

Standardised evaluation of medicine acceptability in paediatric population: reliability of a model
por: Vallet, Thibault, et al.
Publicado: (2017)

Evaluation of comparative soft tissue response to bone void fillers with antibiotics in a rabbit intramuscular model
por: Oliver, Rema A, et al.
Publicado: (2019)

The Application of Failure Modes and Effects Analysis Methodology to Intrathecal Drug Delivery for Pain Management
por: Saulino, Michael F., et al.
Publicado: (2016)

Baicalein inhibits non‐small‐cell lung cancer invasion and metastasis by reducing ezrin tension in inflammation microenvironment
por: Zhang, Xiaolong, et al.
Publicado: (2020)

MET amplification results in heterogeneous responses to osimertinib in EGFR‐mutant lung cancer treated with erlotinib
por: Nishiyama, Akihiro, et al.
Publicado: (2020)

Effect of murine double‐minute 2 inhibitors in preclinical models of advanced clear cell carcinomas originating from ovaries and kidneys
por: Kawata, Yoshiko, et al.
Publicado: (2020)

Intracellular levels of reactive oxygen species correlate with ABT‐263 sensitivity in non‐small‐cell lung cancer cells
por: Ohgino, Keiko, et al.
Publicado: (2020)

Exogenous Surfactant as a Pulmonary Delivery Vehicle for Budesonide In Vivo
por: Baer, Brandon, et al.
Publicado: (2020)

Iron chelation cancer therapy using hydrophilic block copolymers conjugated with deferoxamine
por: Komoto, Kana, et al.
Publicado: (2020)

dUTPase inhibition confers susceptibility to a thymidylate synthase inhibitor in DNA‐repair‐defective human cancer cells
por: Yokogawa, Tatsushi, et al.
Publicado: (2020)

DDEL-10. A NANOPARTICLE PLATFORM FOR INTRATHECAL DELIVERY OF THE HISTONE DEACETYLASE INHIBITOR (HDACi) PANOBINOSTAT IN METASTATIC OR RECURRENT MEDULLOBLASTOMA
por: Chaudhuri, Sauradip, et al.
Publicado: (2020)

DDEL-02. DECREASED TOXICITY OF CONVENTIONAL DOSE CHEMOTHERAPY UTILIZING BODY WEIGHT INSTEAD OF BODY SURFACE AREA FOR DOSING IN YOUNG CHILDREN <6 YEARS OLD ENROLLED ON THE “HEAD START” 4 CLINICAL TRIAL
por: Dhall, Girish, et al.
Publicado: (2020)

DDEL-12. NANOPARTICLE DELIVERY OF DOXORUBICIN FOR THE TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
por: Ung, Caitlin, et al.
Publicado: (2020)

DDEL-03. LONG-TERM INTRAVENTRICULAR THERAPY ALTERNATING ETOPOSIDE AND LIPOSOMAL CYTARABINE: EXPERIENCE IN 75 CHILDREN AND ADOLESCENTS WITH MALIGNANT BRAIN TUMORS
por: Stepien, Natalia, et al.
Publicado: (2020)

DDEL-15. NANOTHERAPEUTIC TARGETING OF TUMOR ENDOTHELIUM FOR ENHANCING DRUG DELIVERY PAST THE BLOOD-BRAIN BARRIER
por: Kiguchi, Hiro, et al.
Publicado: (2020)

DDEL-11. CONVECTION-ENHANCED DELIVERY OF EZH2 INHIBITOR FOR THE TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMA
por: Sasaki, Takahiro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sdj3kp6cl10d2ms6csl6favk9n